Does DACTINOMYCIN Cause Myelosuppression? 84 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Myelosuppression have been filed in association with DACTINOMYCIN (DACTINOMYCIN). This represents 2.9% of all adverse event reports for DACTINOMYCIN.
84
Reports of Myelosuppression with DACTINOMYCIN
2.9%
of all DACTINOMYCIN reports
9
Deaths
43
Hospitalizations
How Dangerous Is Myelosuppression From DACTINOMYCIN?
Of the 84 reports, 9 (10.7%) resulted in death, 43 (51.2%) required hospitalization, and 8 (9.5%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
Yes, Myelosuppression is listed as a known adverse reaction in the official FDA drug label for DACTINOMYCIN.
What Other Side Effects Does DACTINOMYCIN Cause?
Off label use (391)
Febrile neutropenia (226)
Neutropenia (205)
Product use in unapproved indication (203)
Drug ineffective (181)
Disease progression (151)
Vomiting (119)
Anaemia (109)
Thrombocytopenia (106)
Malignant neoplasm progression (103)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which DACTINOMYCIN Alternatives Have Lower Myelosuppression Risk?
DACTINOMYCIN vs DALBAVANCIN
DACTINOMYCIN vs DALFAMPRIDINE
DACTINOMYCIN vs DALTEPARIN
DACTINOMYCIN vs DAMOCTOCOG ALFA PEGOL
DACTINOMYCIN vs DANAPAROID